Frequency of antimicrobal resistance among invasive and colonizing Group B Streptococcal isolates

BMC Infectious Diseases

Volumn 6, Issue , 2006, Pages

  Borchardt, Stephanie M ^a   DeBusscher, Joan H ^a   Tallman, Patricia A ^a   Manning, Shannon D ^a   Marrs, Carl F ^a   Kurzynski, Terrence A ^b   Foxman, Betsy ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b WISCONSIN STATE LABORATORY OF HYGIENE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFAZOLIN; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; PENICILLIN G; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; DOT HYBRIDIZATION; FEMALE; GROUPS BY AGE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NONHUMAN; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS AGALACTIAE; DRUG EFFECT; HETEROZYGOTE; INFANT; MICROBIAL SENSITIVITY TEST; MIDDLE AGED; PRESCHOOL CHILD; TIME;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CARRIER STATE; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; HUMANS; INFANT; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; STREPTOCOCCUS AGALACTIAE; TIME FACTORS;

EID: 33645784639     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-6-57     Document Type: Article

References (25)

1. Schuchat A: Group B streptococcus. Lancet 1999, 353:51-56.
2. Manning SD, Tallman P, Baker CJ, Gillespie B, Marrs CF, Foxman B: Determinants of co-colonization with group B streptococcus among heterosexual college couples. Epidemiology 2002, 13:533-539.
3. Hickman ME, Rench MA, Ferrieri P, Baker CJ: Changing epidemiology of group B streptococcal colonization. Pediatrics 1999, 104:203-209.
4. Yang YH, Zhu YZ, Zhang JH, Shen AD, Zhang GR, Iontova IM, Grabovskaya A, Totolian AA: Group B streptococcal infections in neonates and its carriage in women. Adv in Exp Med and Biol 1997, 418:251-253.
5. Schuchat A: Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev 1998, 11:497-513.
6. CDC: Prevention of perinatal group B streptococcal disease: A public health perspective. MMWR Morb Mortal Wkly Rep 1996, 45(RR-7):1-24.
7. Pearlman MD, Pierson CL, Faix RG: Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin. Obstet Gynecol 1998, 92:258-261.
8. CDC: Prevention of perinatal group B streptococcal disease. MMWR Morb Mortal Wkly Rep 2002, 51 (RR-11): 1-22.
9. Morales WJ, Dickey SS, Bornick P, Lim DV: Change in antibiotic resistance of group B streptococcus: impact on intrapartum management. Am J Obstet Gynecol 1999, 181:310-314.
10. Croak A, Abate G, Goodrum K, Modrzakowski M: Predominance of serotype V and frequency of erythromycin resistance in Streptococcus agalactiae in Ohio. Am J Obstet Gynecol 2003, 188:1148-115O.
11. Manning SD, Foxman B, Pierson CL, Tallman P, Baker CJ, Pearlman MD: Correlates of antibiotic-resistant group B streptococcus isolated from pregnant women. Obstet Gynecol 2003, 101:74-79.
12. Diekema DJ, Andrews JI, Huynh H, Rhomberg PR, Doktor SR, Beyer J, Shortridge VD, Flamm RK, Jones RN, Pfaller MA: Molecular epidemiology of macrolide resistance in neonatal bloodstream isolates of group B streptococci. J Clin Microbiol 2003, 41:2659-2661.
13. Hsueh PR, Teng LJ, Lee LN, Ho SW, Yang PC, Luh KT: High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan. Antimicrob Agents and Chemother 2001, 45:3205-3208.
14. Manning SD, Neighbors K, Tallman P, Gillespie B, Marrs CF, Borchardt SM, Baker CJ, Pearlman MD, Foxman B: Prevalence of group B Streptococcus colonization and potential for transmission by casual contact in healthy young men and women. Clin Infect Dis 2004, 39:380-388.
15. Manning SD, Pearlman MD, Tallman P, Pierson CL, Foxman B: Frequency of antibiotic resistance among group B Streptococcus isolated from healthy college students. Clin Infect Dis 2001, 33:e137-139.
16. NCCLS: Performance standards for antimicrobial susceptibility testing: approved standard. In 12th informational supplement Wayne, PA, CLSI/ NCCLS; 2002:M100-S12.
17. CLSI/NCCLS: Performance standards for antimicrobial susceptibility testing: approved standard. In 15th informational supplement Wayne, PA, CLSI/NCCLS; 2005:M100-S15.
18. Johnson MM, Hill SL, Piddock LJV. Effect of carbon dioxide on testing of susceptibilities of respiratory tract pathogens to macrolide and azalide antimicrobial agents. Antimicrob Agents Chemother 1999, 43:1892-1865.
19. Dibb WL, Diagranes A, Bottolfsen KL: Effects of carbondioxide upon the In Vitro activity of erythromycin. Acta Pathol Microbiol Immunol Scand 1986, 94:173-176.
20. Barry AL, Coyle MB, Thornsberry C, Gerlach EH, Hawkinson RW: Methods of measuring zones of inhibition with the Bauer-Kirby disk susceptibility test. J Clin Microbiol 1979, 10:885-889.
21. Borchardt SM, Foxman B, Chaffin DO, Rubens CE, Tallman PA, Manning SD, Marrs CF: Comparison of DNA dot blot hybridization and Lancefield capillary precipitin methods for group B streptococcal capsular typing. J Clin Microbiol 2004, 42:146-150.
22. Kawamura Y, Fujiwara H, Mishima N, Tanaka Y, Tanimoto A, Ikawa S, Itoh Y, Ezaki T: First Streptococcus agalactiae isolates highly resistant to quinolones, with point mutations in gyrA and parC. Antimicrob Agents Chemother 2003, 47:3605-3609.
23. von Both U, Ruess M, Mueller U, Fluegge K, Sander A, Berner R: A serotype V clone is predominant among erythromycin-resistant Streptococcus agalactiae isolates in a southwestern region of Germany. J Clin Microbiol 2003, 41:2166-2169.
24. Poyart C, Jardy L, Quesne G, Berche P, Trieu-Cuot P: Genetic basis of antibiotic resistance in Streptococcus agalactiae strains isolated in a French hospital. Antimicrob Agents Chemother 2003, 47:794-797.
25. Lin FY, Azimi PH, Weisman LE, Philips JB 3rd, Regan J, Clark P, Rhoads GG, Clemens J, Troendle J, Pratt E, Brenner RA, Gill V: Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998. Clin Infect Dis 2000, 31:76-79.